Home / Resource Library / Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapyInfectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy Key points – The incidence of infections after CD19 CAR